Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 0 | 396 | 442 | 0 | 194 |
| Operating Expenses | 2,115 | 3,956 | 5,512 | 3,191 | 3,398 |
| Operating Income | -2,115 | -3,560 | -5,070 | -3,191 | -3,204 |
| Other Income | 30 | -6 | 64 | 22 | -9 |
| Pre-tax Income | -2,085 | -3,566 | -5,006 | -3,169 | -3,213 |
| Income Tax | -144 | -429 | -963 | -439 | -539 |
| Net Income Continuous | -1,941 | -3,137 | -4,043 | -2,730 | -2,674 |
| Net Income | $-1,941 | $-3,137 | $-4,043 | $-2,730 | $-2,674 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| EBITDA(a) | $-2,046 | $-3,549 | $-5,057 | $-3,175 | $-3,186 |